Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 26Burkitt Lymphoma 6Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myeloid, Acute 3Neoplasm, Residual 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Monocytic, Acute 2Leukemia, Biphenotypic, Acute 2Brain Neoplasms 2Anemia, Refractory 2Thrombocytopenia 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Hodgkin Disease 1

Interventions

Cyclophosphamide 31fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 24Busulfan 22Antilymphocyte Serum 19Filgrastim 17Cyclosporine 16Tacrolimus 15Radiotherapy 15Methotrexate 14Mycophenolic Acid 12Etoposide 12Cytarabine 11Whole-Body Irradiation 10Methylprednisolone 10Melphalan 10Cyclosporins 6Cord Blood Stem Cell Transplantation 6sargramostim 5Psychiatric Rehabilitation 5Flow Cytometry 5ruxolitinib 4Thiotepa 4Thalidomide 4Early Intervention, Educational 4Azacitidine 4Alemtuzumab 4Tretinoin 3Sirolimus 3Polymerase Chain Reaction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Myelodysplastic-Myeloproliferative Diseases × Thioguanine × Clear all
NCT00005823 2013-12-18

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00003593 2013-06-27

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Completed
254 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡